Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 284

1.

Children Immunization App (CImA) Among Syrian Refugees in Zaatari Camp, Jordan: Protocol for a Cluster Randomized Controlled Pilot Trial Intervention Study.

Khader YS, Laflamme L, Schmid D, El-Halabi S, Abu Khdair M, Sengoelge M, Atkins S, Tahtamouni M, Derrough T, El-Khatib Z.

JMIR Res Protoc. 2019 Oct 7;8(10):e13557. doi: 10.2196/13557.

2.

Giant aggressive forehead tumor: A 15-year follow-up.

Challita R, Halabi S.

Clin Pract. 2019 Aug 2;9(3):1172. doi: 10.4081/cp.2019.1172. eCollection 2019 Aug 2.

3.

Phosphorylation of the multi functional signal transducer B-cell adaptor protein (BCAP) promotes recruitment of multiple SH2/SH3 proteins including GRB2.

Lauenstein JU, Udgata A, Bartram A, De Sutter D, Fisher DI, Halabi S, Eyckerman S, Gay NJ.

J Biol Chem. 2019 Sep 16. pii: jbc.RA119.009931. doi: 10.1074/jbc.RA119.009931. [Epub ahead of print]

4.

Phase 2 clinical trial of TORC1 inhibition with everolimus in men with metastatic castration-resistant prostate cancer.

George DJ, Halabi S, Healy P, Jonasch D, Anand M, Rasmussen J, Wood SY, Spritzer C, Madden JF, Armstrong AJ.

Urol Oncol. 2019 Sep 12. pii: S1078-1439(19)30333-3. doi: 10.1016/j.urolonc.2019.08.015. [Epub ahead of print]

PMID:
31522863
5.

Phase 1b trial of docetaxel, prednisone, and pazopanib in men with metastatic castration-resistant prostate cancer.

George DJ, Halabi S, Healy P, Barak I, Winters C, Anand M, Wilder R, Klein M, Martinez E, Nixon AB, Harrison MR, Szmulewitz R, Armstrong AJ.

Prostate. 2019 Nov;79(15):1752-1761. doi: 10.1002/pros.23899. Epub 2019 Sep 9.

PMID:
31497882
6.

Radial Versus Femoral Approach in Women Undergoing Coronary Angiography: A Meta-Analysis of Randomized Controlled Trials.

Al Halabi S, Burke L, Hussain F, Lopez J, Mathew V, Bernat I, Shroff A.

J Invasive Cardiol. 2019 Aug 15. pii: JIC2019815-1. [Epub ahead of print]

7.

Cabozantinib Versus Sunitinib for Untreated Patients with Advanced Renal Cell Carcinoma of Intermediate or Poor Risk: Subgroup Analysis of the Alliance A031203 CABOSUN trial.

George DJ, Hessel C, Halabi S, Michaelson MD, Hahn O, Walsh M, Picus J, Small EJ, Dakhil S, Feldman DR, Mangeshkar M, Scheffold C, Morris MJ, Choueiri TK.

Oncologist. 2019 Aug 9. pii: theoncologist.2019-0316. doi: 10.1634/theoncologist.2019-0316. [Epub ahead of print]

PMID:
31399500
8.

A Systematic Review and Recommendation for Reporting of Surrogate Endpoint Evaluation Using Meta-analyses.

Xie W, Halabi S, Tierney JF, Sydes MR, Collette L, Dignam JJ, Buyse M, Sweeney CJ, Regan MM.

JNCI Cancer Spectr. 2019 Feb 6;3(1):pkz002. doi: 10.1093/jncics/pkz002. eCollection 2019 Mar. Review.

9.

Universal Testing, Expanded Treatment, and Incidence of HIV Infection in Botswana.

Makhema J, Wirth KE, Pretorius Holme M, Gaolathe T, Mmalane M, Kadima E, Chakalisa U, Bennett K, Leidner J, Manyake K, Mbikiwa AM, Simon SV, Letlhogile R, Mukokomani K, van Widenfelt E, Moyo S, Lebelonyane R, Alwano MG, Powis KM, Dryden-Peterson SL, Kgathi C, Novitsky V, Moore J, Bachanas P, Abrams W, Block L, El-Halabi S, Marukutira T, Mills LA, Sexton C, Raizes E, Gaseitsiwe S, Bussmann H, Okui L, John O, Shapiro RL, Pals S, Michael H, Roland M, DeGruttola V, Lei Q, Wang R, Tchetgen Tchetgen E, Essex M, Lockman S.

N Engl J Med. 2019 Jul 18;381(3):230-242. doi: 10.1056/NEJMoa1812281.

PMID:
31314967
10.

Reply to L. Dirix, B. De Laere et al, and A. Sharp et al.

Armstrong AJ, Halabi S, Luo J, Nanus DM, Scher HI, Antonarakis ES, George DJ.

J Clin Oncol. 2019 Aug 20;37(24):2184-2186. doi: 10.1200/JCO.19.01230. Epub 2019 Jul 2. No abstract available.

PMID:
31265357
11.

Deep Learning-Assisted Diagnosis of Cerebral Aneurysms Using the HeadXNet Model.

Park A, Chute C, Rajpurkar P, Lou J, Ball RL, Shpanskaya K, Jabarkheel R, Kim LH, McKenna E, Tseng J, Ni J, Wishah F, Wittber F, Hong DS, Wilson TJ, Halabi S, Basu S, Patel BN, Lungren MP, Ng AY, Yeom KW.

JAMA Netw Open. 2019 Jun 5;2(6):e195600. doi: 10.1001/jamanetworkopen.2019.5600.

12.

The evolution and understanding of skeletal complication endpoints in clinical trials of tumors with metastasis to the bone.

Hussain A, Lee RJ, Graff JN, Halabi S.

Crit Rev Oncol Hematol. 2019 Jul;139:108-116. doi: 10.1016/j.critrevonc.2019.04.020. Epub 2019 Apr 30. Review.

13.

Pharmacodynamic study of radium-223 in men with bone metastatic castration resistant prostate cancer.

Armstrong AJ, Gupta S, Healy P, Kemeny G, Leith B, Zalutsky MR, Spritzer C, Davies C, Rothwell C, Ware K, Somarelli JA, Wood K, Ribar T, Giannakakou P, Zhang J, Gerber D, Anand M, Foo WC, Halabi S, Gregory SG, George DJ.

PLoS One. 2019 May 28;14(5):e0216934. doi: 10.1371/journal.pone.0216934. eCollection 2019.

14.

Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality.

Dess RT, Hartman HE, Mahal BA, Soni PD, Jackson WC, Cooperberg MR, Amling CL, Aronson WJ, Kane CJ, Terris MK, Zumsteg ZS, Butler S, Osborne JR, Morgan TM, Mehra R, Salami SS, Kishan AU, Wang C, Schaeffer EM, Roach M 3rd, Pisansky TM, Shipley WU, Freedland SJ, Sandler HM, Halabi S, Feng FY, Dignam JJ, Nguyen PL, Schipper MJ, Spratt DE.

JAMA Oncol. 2019 Jul 1;5(7):975-983. doi: 10.1001/jamaoncol.2019.0826.

15.

On the use of min-max combination of biomarkers to maximize the partial area under the ROC curve.

Ma H, Halabi S, Liu A.

J Probab Stat. 2019;2019. pii: 8953530. doi: 10.1155/2019/8953530. Epub 2019 Feb 3.

16.

Deep learning to automate Brasfield chest radiographic scoring for cystic fibrosis.

Zucker EJ, Barnes ZA, Lungren MP, Shpanskaya Y, Seekins JM, Halabi SS, Larson DB.

J Cyst Fibros. 2019 May 2. pii: S1569-1993(19)30075-X. doi: 10.1016/j.jcf.2019.04.016. [Epub ahead of print]

PMID:
31056440
17.

Androgen decline and survival during docetaxel therapy in metastatic castration resistant prostate cancer (mCRPC).

Ryan CJ, Dutta S, Kelly WK, Russell C, Small EJ, Morris MJ, Taplin ME, Halabi S; From The Alliance for Clinical Trials in Oncology Genitourinary Committee.

Prostate Cancer Prostatic Dis. 2019 May 3. doi: 10.1038/s41391-019-0152-3. [Epub ahead of print]

PMID:
31053766
18.

Effectiveness of digital technologies at improving vaccine uptake and series completion - A systematic review and meta-analysis of randomized controlled trials.

Atkinson KM, Wilson K, Murphy MSQ, El-Halabi S, Kahale LA, Laflamme LL, El-Khatib Z.

Vaccine. 2019 May 21;37(23):3050-3060. doi: 10.1016/j.vaccine.2019.03.063. Epub 2019 Apr 26. Review.

PMID:
31036457
19.

Adhesion durability of dual-cure resin cements and acid-base resistant zone formation on human dentin.

Aung SSMP, Takagaki T, Ko AK, Halabi S, Sato T, Ikeda M, Nikaido T, Burrow MF, Tagami J.

Dent Mater. 2019 Jul;35(7):945-952. doi: 10.1016/j.dental.2019.02.020. Epub 2019 Apr 26.

PMID:
31036261
20.

Group-sequential logrank methods for trial designs using bivariate non-competing event-time outcomes.

Sugimoto T, Hamasaki T, Evans SR, Halabi S.

Lifetime Data Anal. 2019 Apr 12. doi: 10.1007/s10985-019-09470-4. [Epub ahead of print]

PMID:
30980317
21.

Effect of Office Bleaching on Enamel Bonding Performance.

Halabi S, Matsui N, Nikaido T, Burrow MF, Tagami J.

J Adhes Dent. 2019;21(2):167-177. doi: 10.3290/j.jad.a42362.

PMID:
30949630
22.

Sonographic Diagnosis of Velamentous and Marginal Placental Cord Insertion.

Kelley BP, Klochko CL, Atkinson S, Hillman D, Craig BM, Sandberg SA, Gaba AR, Halabi SS.

Ultrasound Q. 2019 Mar 11. doi: 10.1097/RUQ.0000000000000437. [Epub ahead of print]

PMID:
30870317
23.

Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study.

Armstrong AJ, Halabi S, Luo J, Nanus DM, Giannakakou P, Szmulewitz RZ, Danila DC, Healy P, Anand M, Rothwell CJ, Rasmussen J, Thornburg B, Berry WR, Wilder RS, Lu C, Chen Y, Silberstein JL, Kemeny G, Galletti G, Somarelli JA, Gupta S, Gregory SG, Scher HI, Dittamore R, Tagawa ST, Antonarakis ES, George DJ.

J Clin Oncol. 2019 May 1;37(13):1120-1129. doi: 10.1200/JCO.18.01731. Epub 2019 Mar 13.

PMID:
30865549
24.

Integrating noncommunicable disease services into primary health care, Botswana.

Tapela NM, Tshisimogo G, Shatera BP, Letsatsi V, Gaborone M, Madidimalo T, Ovberedjo M, Jibril HB, Tsima B, Nkomazana O, Dryden-Peterson S, Lockman S, Masupe T, Hirschhorn LR, El Halabi S.

Bull World Health Organ. 2019 Feb 1;97(2):142-153. doi: 10.2471/BLT.18.221424. Epub 2019 Jan 8.

25.

Evidence Synthesis to Accelerate and Improve the Evaluation of Therapies for Metastatic Hormone-sensitive Prostate Cancer.

Tierney JF, Vale CL, Parelukar WR, Rydzewska L, Halabi S.

Eur Urol Focus. 2019 Mar;5(2):137-143. doi: 10.1016/j.euf.2019.01.005. Epub 2019 Feb 1. Review.

PMID:
30713089
26.

Rationale and Design of the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Mangat PK, Halabi S, Bruinooge SS, Garrett-Mayer E, Alva A, Janeway KA, Stella PJ, Voest E, Yost KJ, Perlmutter J, Pinto N, Kim ES, Schilsky RL.

JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.18.00122. Epub 2018 Jul 11.

27.

Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel.

Halabi S, Dutta S, Tangen CM, Rosenthal M, Petrylak DP, Thompson IM Jr, Chi KN, Araujo JC, Logothetis C, Quinn DI, Fizazi K, Morris MJ, Eisenberger MA, George DJ, De Bono JS, Higano CS, Tannock IF, Small EJ, Kelly WK.

J Clin Oncol. 2019 Feb 10;37(5):403-410. doi: 10.1200/JCO.18.01279. Epub 2018 Dec 21.

PMID:
30576268
28.

Deep-learning-assisted diagnosis for knee magnetic resonance imaging: Development and retrospective validation of MRNet.

Bien N, Rajpurkar P, Ball RL, Irvin J, Park A, Jones E, Bereket M, Patel BN, Yeom KW, Shpanskaya K, Halabi S, Zucker E, Fanton G, Amanatullah DF, Beaulieu CF, Riley GM, Stewart RJ, Blankenberg FG, Larson DB, Jones RH, Langlotz CP, Ng AY, Lungren MP.

PLoS Med. 2018 Nov 27;15(11):e1002699. doi: 10.1371/journal.pmed.1002699. eCollection 2018 Nov.

29.

The RSNA Pediatric Bone Age Machine Learning Challenge.

Halabi SS, Prevedello LM, Kalpathy-Cramer J, Mamonov AB, Bilbily A, Cicero M, Pan I, Pereira LA, Sousa RT, Abdala N, Kitamura FC, Thodberg HH, Chen L, Shih G, Andriole K, Kohli MD, Erickson BJ, Flanders AE.

Radiology. 2019 Feb;290(2):498-503. doi: 10.1148/radiol.2018180736. Epub 2018 Nov 27.

PMID:
30480490
30.

Deep learning for chest radiograph diagnosis: A retrospective comparison of the CheXNeXt algorithm to practicing radiologists.

Rajpurkar P, Irvin J, Ball RL, Zhu K, Yang B, Mehta H, Duan T, Ding D, Bagul A, Langlotz CP, Patel BN, Yeom KW, Shpanskaya K, Blankenberg FG, Seekins J, Amrhein TJ, Mong DA, Halabi SS, Zucker EJ, Ng AY, Lungren MP.

PLoS Med. 2018 Nov 20;15(11):e1002686. doi: 10.1371/journal.pmed.1002686. eCollection 2018 Nov.

31.

Combined Performance of Screening and Variable Selection Methods in Ultra-High Dimensional Data in Predicting Time-To-Event Outcomes.

Pi L, Halabi S.

Diagn Progn Res. 2018;2. pii: 21. doi: 10.1186/s41512-018-0043-4. Epub 2018 Sep 26.

32.

Management of recurrent prostate cancer after radiotherapy: long-term results from CALGB 9687 (Alliance), a prospective multi-institutional salvage prostatectomy series.

Mohler JL, Halabi S, Ryan ST, Al-Daghmin A, Sokoloff MH, Steinberg GD, Sanford BL, Eastham JA, Walther PJ, Morris MJ, Small EJ.

Prostate Cancer Prostatic Dis. 2019 May;22(2):309-316. doi: 10.1038/s41391-018-0106-1. Epub 2018 Nov 1.

33.

Migrating to the Modern PACS: Challenges and Opportunities.

Berkowitz SJ, Wei JL, Halabi S.

Radiographics. 2018 Oct;38(6):1761-1772. doi: 10.1148/rg.2018180161. Review.

PMID:
30303805
34.

Corrigendum to 'Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update' [Eur J Cancer 94 (May 2018) 115-125].

Choueiri TK, Hessel C, Halabi S, Sanford B, Michaelson MD, Hahn O, Walsh M, Olencki T, Picus J, Small EJ, Dakhil S, Feldman DR, Mangeshkar M, Scheffold C, George D, Morris MJ.

Eur J Cancer. 2018 Nov;103:287. doi: 10.1016/j.ejca.2018.09.022. Epub 2018 Sep 27. No abstract available.

35.

Power matters: The role of power and morality needs in competitive victimhood among advantaged and disadvantaged groups.

Kahalon R, Shnabel N, Halabi S, SimanTov-Nachlieli I.

Br J Soc Psychol. 2018 Aug 29. doi: 10.1111/bjso.12276. [Epub ahead of print]

PMID:
30156303
36.

Off-Label Marketing's Audiences: The 21st Century Cures Act and the Relaxation of Standards for Evidence-Based Therapeutic and Cost-Comparative Claims.

Halabi SF.

Am J Law Med. 2018 May;44(2-3):181-196. doi: 10.1177/0098858818789420. No abstract available.

PMID:
30106659
37.

Improving Door-to-Balloon Time of Patients with ST-Segment Elevation Myocardial Infarction (STEMI) in the Emergency Department.

Halabi S, Elias A, Goldberg M, Hurani H, Darawsha H, Shachar S, Ashkenazi M.

Isr Med Assoc J. 2018 Aug;20(8):476-479.

38.

The association between cardiovascular disease gene mutations and recurrent pregnancy loss in the Lebanese population.

El Achi H, Awwad J, Abou Daya S, Halabi S, Damianos S, Mahfouz R.

Mol Biol Rep. 2018 Oct;45(5):911-916. doi: 10.1007/s11033-018-4237-1. Epub 2018 Jul 4.

PMID:
29974397
39.

Future time perspective and interpersonal empathy: Implications for preferring autonomy- versus dependency-oriented helping.

Chernyak-Hai L, Halabi S.

Br J Soc Psychol. 2018 Oct;57(4):793-814. doi: 10.1111/bjso.12260. Epub 2018 Jun 21.

PMID:
29926924
40.

Health Data and Privacy in the Digital Era.

Gostin LO, Halabi SF, Wilson K.

JAMA. 2018 Jul 17;320(3):233-234. doi: 10.1001/jama.2018.8374. No abstract available.

PMID:
29926092
41.

Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance).

Li M, Mulkey F, Jiang C, O'Neil BH, Schneider BP, Shen F, Friedman PN, Momozawa Y, Kubo M, Niedzwiecki D, Hochster HS, Lenz HJ, Atkins JN, Rugo HS, Halabi S, Kelly WK, McLeod HL, Innocenti F, Ratain MJ, Venook AP, Owzar K, Kroetz DL.

Clin Cancer Res. 2018 Oct 1;24(19):4734-4744. doi: 10.1158/1078-0432.CCR-17-1523. Epub 2018 Jun 5.

42.

Meta-Analysis of Studies Comparing Dual- Versus Mono-Antiplatelet Therapy Following Transcatheter Aortic Valve Implantation.

Al Halabi S, Newman J, Farkouh ME, Fortuin D, Leya F, Sweeney J, Darki A, Lopez J, Steen L, Lewis B, Webb J, Leon MB, Mathew V.

Am J Cardiol. 2018 Jul 1;122(1):141-148. doi: 10.1016/j.amjcard.2018.03.019. Epub 2018 Mar 28. Review.

PMID:
29779587
43.

Lack of Virological Suppression Among Young HIV-Positive Adults in Botswana.

Novitsky V, Gaolathe T, Mmalane M, Moyo S, Chakalisa U, Yankinda EK, Marukutira T, Holme MP, Sekoto T, Gaseitsiwe S, Musonda R, van Widenfelt E, Powis KM, Khan N, Dryden-Peterson S, Bennett K, Wirth KE, Tchetgen ET, Bachanas P, Mills LA, Lebelonyane R, El-Halabi S, Makhema J, Lockman S, Essex M.

J Acquir Immune Defic Syndr. 2018 Aug 15;78(5):557-565. doi: 10.1097/QAI.0000000000001715.

44.

Comparison of air exhausts for surgical body suits (space suits) and the potential for periprosthetic joint infection.

Ling F, Halabi S, Jones C.

J Hosp Infect. 2018 Jul;99(3):279-283. doi: 10.1016/j.jhin.2018.03.012. Epub 2018 Mar 17.

PMID:
29559232
45.

Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update.

Choueiri TK, Hessel C, Halabi S, Sanford B, Michaelson MD, Hahn O, Walsh M, Olencki T, Picus J, Small EJ, Dakhil S, Feldman DR, Mangeshkar M, Scheffold C, George D, Morris MJ.

Eur J Cancer. 2018 May;94:115-125. doi: 10.1016/j.ejca.2018.02.012. Epub 2018 Mar 20. Erratum in: Eur J Cancer. 2018 Nov;103:287.

46.

Data Science: Big Data, Machine Learning, and Artificial Intelligence.

Carlos RC, Kahn CE, Halabi S.

J Am Coll Radiol. 2018 Mar;15(3 Pt B):497-498. doi: 10.1016/j.jacr.2018.01.029. No abstract available. Erratum in: J Am Coll Radiol. 2018 May;15(5):819.

PMID:
29502583
47.

Translational Radiomics: Defining the Strategy Pipeline and Considerations for Application-Part 1: From Methodology to Clinical Implementation.

Shaikh F, Franc B, Allen E, Sala E, Awan O, Hendrata K, Halabi S, Mohiuddin S, Malik S, Hadley D, Shrestha R.

J Am Coll Radiol. 2018 Mar;15(3 Pt B):538-542. doi: 10.1016/j.jacr.2017.12.008. Epub 2018 Feb 1. Review.

PMID:
29366600
48.

Translational Radiomics: Defining the Strategy Pipeline and Considerations for Application-Part 2: From Clinical Implementation to Enterprise.

Shaikh F, Franc B, Allen E, Sala E, Awan O, Hendrata K, Halabi S, Mohiuddin S, Malik S, Hadley D, Shrestha R.

J Am Coll Radiol. 2018 Mar;15(3 Pt B):543-549. doi: 10.1016/j.jacr.2017.12.006. Epub 2018 Feb 1. Review.

PMID:
29366598
49.

Role of Bone-Modifying Agents in Multiple Myeloma: American Society of Clinical Oncology Clinical Practice Guideline Update.

Anderson K, Ismaila N, Flynn PJ, Halabi S, Jagannath S, Ogaily MS, Omel J, Raje N, Roodman GD, Yee GC, Kyle RA.

J Clin Oncol. 2018 Mar 10;36(8):812-818. doi: 10.1200/JCO.2017.76.6402. Epub 2018 Jan 17.

PMID:
29341831
50.

A Simple Method for Deriving the Confidence Regions for the Penalized Cox's Model via the Minimand Perturbation.

Lin CY, Halabi S.

Commun Stat Theory Methods. 2017;46(10):4791-4808. doi: 10.1080/03610926.2015.1085568. Epub 2016 May 18.

Supplemental Content

Loading ...
Support Center